M&A

Illustration connected puzzle pieces with the acronym MA
Biotech

Ipsen inks €1B buyout of French biotech ImCheck

Ipsen is acquiring next-gen immuno-oncology biotech ImCheck for its investigational cancer combo therapy in a deal worth up $1.16 billion.
Gabrielle Masson Oct 22, 2025 10:33am
puzzle pieces merger and acquisition business concept

Hologic to go private with $18.3B deal by Blackstone and TPG

Oct 22, 2025 8:45am
MA

Boston Scientific to drop $533M to acquire Nalu Medical

Oct 20, 2025 12:04pm
Heat red cracked ground texture burning after volcano eruption Molten active lava texture background

Xoma and Lava buyout cools with lower offer

Oct 17, 2025 2:35pm
Torley
Favicon Fierce Pharma

Halozyme CEO targets new deals as IRA uncertainty subsides

Oct 14, 2025 9:40am
An open book with pages turning on a wooden table set

J&J eyes takeover of immunology partner Protagonist: WSJ

Oct 10, 2025 2:30pm